BDBM62549 1-(Toluene-4-sulfonyl)-piperidine-3-carboxylic acid (2-benzo[1,3]dioxol-5-yl-ethyl)-amide::MLS000072111::N-[2-(1,3-benzodioxol-5-yl)ethyl]-1-(4-methylphenyl)sulfonyl-3-piperidinecarboxamide::N-[2-(1,3-benzodioxol-5-yl)ethyl]-1-(4-methylphenyl)sulfonyl-piperidine-3-carboxamide::N-[2-(1,3-benzodioxol-5-yl)ethyl]-1-(4-methylphenyl)sulfonylpiperidine-3-carboxamide::N-homopiperonyl-1-tosyl-nipecotamide::SMR000004271::cid_650909

SMILES COCCn1nc2cc(N3CCCc4cc(C(=O)N5CCCCC5)cnc43)ccn2c1=O

InChI Key InChIKey=NRUQFDVIYWDITN-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62549   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62549BDBM62549(US12577217, Example 1-55)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent